Los Angeles Capital Management LLC Y M Abs Therapeutics, Inc. Transaction History

Los Angeles Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 05, 2024	SELL	$6.57 - $18.69 $1.5 Million - $4.28 Million	-228,979 Reduced 64.22%	127,551 $2.07 Million
Q4 2023 Feb 06, 2024	BUY	$4.88 - $7.42 $256,736 - $390,366	52,610 Added 17.31%	356,530 $2.43 Million
Q3 2023 Nov 06, 2023	BUY	$4.86 - $7.23 $160,350 - $238,546	32,994 Added 12.18%	303,920 $1.66 Million
Q2 2023 Aug 03, 2023	BUY	$5.68 - $10.34 $1.54 Million - $2.8 Million	270,926 New	270,926 $1.84 Million
Q2 2021 Aug 05, 2021	SELL	$25.45 - $37.64 $211,107 - $312,223	-8,295 Closed	0 $0
Q1 2021 May 05, 2021	SELL	$29.16 - $51.96 $103,634 - $184,665	-3,554 Reduced 29.99%	8,295 $250,000
Q4 2020 Feb 04, 2021	SELL	$37.86 - $54.26 $4,732 - $6,782	-125 Reduced 1.04%	11,849 $587,000
Q3 2020 Nov 02, 2020	BUY	$35.13 - $43.62 $420,646 - $522,305	11,974 New	11,974 $460,000

106

24.5M

40.3K

400

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $487M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.